Company Description
Biocon. The Group's principal activity is to manufacture biotechnological products through fermentation based technology. The Group operates in three business segments: Enzymes, Active pharmaceutical ingredients and Contract research services. ...
Related Business Topics
Breaking News
Forbes.com - November 17, 2009 4:37 PM
Kiran Mazumdar-Shaw is Chairman and Managing Director of Biocon but, more importantly, she is India's bio-tech queen. I am sitting in her tastefully appointed office, which reflects reasoned self-confidence, genetic engineering and works from painter ...
Forbes.com - November 02, 2009 12:59 PM
- Follow-On Results from a Randomized Phase IIb Head & Neck Trial Demonstrate Efficacy of Nimotuzumab Without Severe, Class-Associated Toxicities - MISSISSAUGA, ON 'These data are convincing evidence that nimotuzumab is an efficacious and safe drug and ...
CNBC - September 10, 2009 3:35 PM
NEW YORK - Amylin Pharmaceuticals Inc. said Thursday it will partner with Biocon Ltd. of India to develop and market a biotech diabetes drug. Terms of the collaboration were not disclosed. The companies said they will share development ...
Forbes.com - September 10, 2009 3:10 PM
Reuters - September 10, 2009 2:47 PM
Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid Program will Focus on the Potential Treatment of Diabetes SAN DIEGO and BANGALORE, India, Sept. 10 /PRNewswire-FirstCall/ -- ...
Harvard Business School
Leadership & Strategy Program for Pharma & Biotech Executives.
www.exed.hbs.edu
Leadership & Strategy Program for Pharma & Biotech Executives.
www.exed.hbs.edu
Top 60 India Biopharm DIR
New India's Top 60 Biopharmas Directory and in-depth Profiles!
www.bioplanassociates.com/india
New India's Top 60 Biopharmas Directory and in-depth Profiles!
www.bioplanassociates.com/india
